| Tamara Rimash, MD | |
|
111 Colchester Ave, Burlington, VT 05401-1473 | |
| (802) 847-0000 | |
| Not Available |
| Full Name | Tamara Rimash |
|---|---|
| Gender | Female |
| Speciality | Otolaryngology |
| Experience | 23 Years |
| Location | 111 Colchester Ave, Burlington, Vermont |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013136159 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 231394 (Massachusetts) | Secondary |
| 207Y00000X | Otolaryngology | 042.0011676 (Vermont) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Univ. Of Vermont - Fletcher Allen Health Care | Burlington, VT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Vermont Medical Center Inc | 3779491071 | 994 |
News Archive
The Precision Fluidics Division of Parker Hannifin Corporation, the global leader in motion and control technologies, announces the launch of its newest model addition in the miniature high pressure high flow proportional valve series VSO MAX HP for OEMs looking for innovation in controlling the flow of inert gases.
A cancer drug called bosutinib may inhibit the growth of cysts in patients with autosomal dominant polycystic kidney disease (ADPKD), according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology.
Patients with high blood pressure and progression of periventricular white matter hyperintensities showed signs of cognitive impairment despite taking medication to lower their blood pressure, according to new research in the American Heart Association's journal Hypertension.
The global COVID-19 pandemic could significantly increase the global burden of tuberculosis (TB) due to disruptions to health services, and delays to diagnosis and treatment, according to new estimates published in the European Respiratory Journal.
ChemoCentryx, Inc. today announced that CCX140, the Company's novel, orally active CCR2 antagonist successfully met its primary endpoint of safety and tolerability and demonstrated clinical efficacy in a Phase II study in patients with type 2 diabetes on stable doses of metformin.
› Verified 4 days ago
| Entity Name | University Of Vermont Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659309615 PECOS PAC ID: 3779491071 Enrollment ID: O20040406001047 |
News Archive
The Precision Fluidics Division of Parker Hannifin Corporation, the global leader in motion and control technologies, announces the launch of its newest model addition in the miniature high pressure high flow proportional valve series VSO MAX HP for OEMs looking for innovation in controlling the flow of inert gases.
A cancer drug called bosutinib may inhibit the growth of cysts in patients with autosomal dominant polycystic kidney disease (ADPKD), according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology.
Patients with high blood pressure and progression of periventricular white matter hyperintensities showed signs of cognitive impairment despite taking medication to lower their blood pressure, according to new research in the American Heart Association's journal Hypertension.
The global COVID-19 pandemic could significantly increase the global burden of tuberculosis (TB) due to disruptions to health services, and delays to diagnosis and treatment, according to new estimates published in the European Respiratory Journal.
ChemoCentryx, Inc. today announced that CCX140, the Company's novel, orally active CCR2 antagonist successfully met its primary endpoint of safety and tolerability and demonstrated clinical efficacy in a Phase II study in patients with type 2 diabetes on stable doses of metformin.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tamara Rimash, MD 111 Colchester Ave, Burlington, VT 05401-1473 Ph: (802) 847-0000 | Tamara Rimash, MD 111 Colchester Ave, Burlington, VT 05401-1473 Ph: (802) 847-0000 |
News Archive
The Precision Fluidics Division of Parker Hannifin Corporation, the global leader in motion and control technologies, announces the launch of its newest model addition in the miniature high pressure high flow proportional valve series VSO MAX HP for OEMs looking for innovation in controlling the flow of inert gases.
A cancer drug called bosutinib may inhibit the growth of cysts in patients with autosomal dominant polycystic kidney disease (ADPKD), according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology.
Patients with high blood pressure and progression of periventricular white matter hyperintensities showed signs of cognitive impairment despite taking medication to lower their blood pressure, according to new research in the American Heart Association's journal Hypertension.
The global COVID-19 pandemic could significantly increase the global burden of tuberculosis (TB) due to disruptions to health services, and delays to diagnosis and treatment, according to new estimates published in the European Respiratory Journal.
ChemoCentryx, Inc. today announced that CCX140, the Company's novel, orally active CCR2 antagonist successfully met its primary endpoint of safety and tolerability and demonstrated clinical efficacy in a Phase II study in patients with type 2 diabetes on stable doses of metformin.
› Verified 4 days ago
Dr. George Kurien, MD FRCSC Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-4537 Fax: 802-847-8198 | |
Erin Tracy Ostby, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave Fl 4, Burlington, VT 05401 Phone: 802-847-4535 Fax: 802-847-8198 | |
Dr. William John Brundage, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, West Pavilion-level 4, Burlington, VT 05401 Phone: 802-847-4535 Fax: 802-847-8198 | |
Dr. Donna Jean Millay, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave, West Pavilion-level 4 Otolaryngology, Burlington, VT 05401 Phone: 802-847-4537 Fax: 802-847-8198 | |
Dr. Gary Patrick Landrigan, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave, West Pavilion-level 4, Burlington, VT 05401 Phone: 802-847-9393 Fax: 802-847-8198 | |
Heather Chambless Herrington, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-2700 |